These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10413393)

  • 1. An international comparison of the reliability and responsiveness of the Duke Health Profile for measuring health-related quality of life of patients treated with alprostadil for erectile dysfunction.
    Parkerson GR; Willke RJ; Hays RD
    Med Care; 1999 Jan; 37(1):56-67. PubMed ID: 10413393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life effects of alprostadil therapy for erectile dysfunction: results of a trial in Europe and South Africa.
    Willke RJ; Yen W; Parkerson GR; Linet OI; Erder MH; Glick HA
    Int J Impot Res; 1998 Dec; 10(4):239-46. PubMed ID: 9884920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life effects of alprostadil therapy for erectile dysfunction.
    Willke RJ; Glick HA; McCarron TJ; Erder MH; Althof SE; Linet OI
    J Urol; 1997 Jun; 157(6):2124-8. PubMed ID: 9146597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term, multicenter study of the safety and efficacy of topical alprostadil cream in male patients with erectile dysfunction.
    Rooney M; Pfister W; Mahoney M; Nelson M; Yeager J; Steidle C
    J Sex Med; 2009 Feb; 6(2):520-34. PubMed ID: 19138370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erection hardness score for the evaluation of erectile dysfunction: further psychometric assessment in patients treated by intracavernous prostaglandins injections after radical prostatectomy.
    Parisot J; Yiou R; Salomon L; de la Taille A; Lingombet O; Audureau E
    J Sex Med; 2014 Aug; 11(8):2109-18. PubMed ID: 24840184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Duke Health Profile. A 17-item measure of health and dysfunction.
    Parkerson GR; Broadhead WE; Tse CK
    Med Care; 1990 Nov; 28(11):1056-72. PubMed ID: 2250492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of intracavernosal alprostadil in erectile dysfunction.
    Gingell C
    Hosp Med; 1998 Oct; 59(10):777. PubMed ID: 9850293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and initial validation of a new preference-based disease-specific health-related quality of life instrument for erectile function.
    Torrance GW; Keresteci MA; Casey RW; Rosner AJ; Ryan N; Breton MC
    Qual Life Res; 2004 Mar; 13(2):349-59. PubMed ID: 15085907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
    Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
    Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of colour duplex ultrasonography after transurethral alprostadil and intracavernous alprostadil in the assessment of erectile dysfunction.
    Ahn HS; Lee SW; Yoon SJ; Hann HJ; Hong JM
    J Int Med Res; 2004; 32(3):317-23. PubMed ID: 15174226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalassaemic men affected by erectile dysfunction treated with transurethral alprostadil: case report.
    Lombardo T; Giammusso B; Frontini V; D'Arpa S; Pafumi C; Caruso S
    Hum Reprod; 2000 Nov; 15(11):2375-8. PubMed ID: 11056136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of medications for erectile dysfunction in the United States, 1996 through 2001.
    Wysowski DK; Swann J
    J Urol; 2003 Mar; 169(3):1040-2. PubMed ID: 12576841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching from intracavernous prostaglandin E1 injections to oral sildenafil citrate in patients with erectile dysfunction: results of a multicenter European study. The Sildenafil Multicenter Study Group.
    Giuliano F; Montorsi F; Mirone V; Rossi D; Sweeney M
    J Urol; 2000 Sep; 164(3 Pt 1):708-11. PubMed ID: 10953130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual rehabilitation and penile pain associated with intracavernous alprostadil after radical prostatectomy.
    Yiou R; Cunin P; de la Taille A; Salomon L; Binhas M; Lingombet O; Paul M; Abbou C
    J Sex Med; 2011 Feb; 8(2):575-82. PubMed ID: 20807323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy.
    Costabile RA; Spevak M; Fishman IJ; Govier FE; Hellstrom WJ; Shabsigh R; Nemo KJ; Rapport JL; Tam PY; Weldon KL; Gesundheit N
    J Urol; 1998 Oct; 160(4):1325-8. PubMed ID: 9751346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The opinion of patients treated with intracavernous injections: the EASY survey].
    Desvaux P; Alexandre B
    Presse Med; 2005 Jul; 34(13 Suppl):10-2. PubMed ID: 16158022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of transurethral alprostadil on the quality of life of men with erectile dysfunction, and their partners. MUSE Study Group.
    Williams G; Abbou CC; Amar ET; Desvaux P; Flam TA; Lycklama à Nijeholt GA; Lynch SF; Morgan RJ; Müller SC; Porst H; Pryor JP; Ryan P; Witzsch UK; Hall MM; Place VA; Spivack AP; Todd LK; Gesundheit N
    Br J Urol; 1998 Dec; 82(6):847-54. PubMed ID: 9883223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind multicenter study comparing alprostadil alpha-cyclodextrin with moxisylyte chlorhydrate in patients with chronic erectile dysfunction.
    Buvat J; Costa P; Morlier D; Lecocq B; Stegmann B; Albrecht D
    J Urol; 1998 Jan; 159(1):116-9. PubMed ID: 9400450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erectile response to transurethral alprostadil, prazosin and alprostadil-prazosin combinations.
    Peterson CA; Bennett AH; Hellstrom WJ; Kaiser FE; Morley JE; Nemo KJ; Padma-Nathan H; Place VA; Prendergast JJ; Tam PY; Tanagho EA; Todd LK; Varady JC; Gesundheit N
    J Urol; 1998 May; 159(5):1523-7; discussion 1527-8. PubMed ID: 9554347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil.
    Hellstrom WJ; Bennett AH; Gesundheit N; Kaiser FE; Lue TF; Padma-Nathan H; Peterson CA; Tam PY; Todd LK; Varady JC; Place VA
    Urology; 1996 Dec; 48(6):851-6. PubMed ID: 8973666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.